Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression.
Serdar Can GüvenAbdulsamet ErdenHamit KüçükHakan ApaydınBünyamin PolatRıza Can KardaşDerya YıldırımEren UsulBerkan ArmağanOrhan KüçükşahinAhmet OmmaAbdurrahman TufanPublished in: European journal of rheumatology (2024)
Despite high rates of hospitalization in AA amyloidosis patients, mortality was observed only in 1 patient. Progression of proteinuria requiring treatment adjustment may be an issue in these patients. Cite this article as: Güven SC, Erden A, Küçük H, et al. Coronavirus disease 2019 outcomes in amyloid A protein amyloidosis secondary to rheumatic conditions and signs of post-coronavirus disease 2019 proteinuria progression. Eur J Rheumatol. Published online April 4, 2024. DOI:10.5152/eurjrheum.2024.23050.
Keyphrases
- coronavirus disease
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- rheumatoid arthritis
- peritoneal dialysis
- prognostic factors
- coronary artery disease
- social media
- case report
- small molecule
- cardiovascular events
- risk factors
- patient reported
- smoking cessation
- glycemic control
- replacement therapy